Transcriptomics

Dataset Information

0

ELAVL3 stabilizes MYCN mRNA and provides a therapeutic target in neuroendocrine prostate cancer [LNCaP/AR/shTP53/shRB1]


ABSTRACT: Here we demonstrated that the RNA-binding protein ELAVL3 is specifically upregulated in NEPC, and that overexpression of ELAVL3 alone sufficiently induce neuroendocrine phenotype in prostate adenocarcinoma. Pharmacological inhibition of ELAVL3 with pyrvinium pamoate, an FDA-approved drug, effectively suppressed tumor growth, reduced the risk of metastases, and improved the survival of NEPC mice models.

ORGANISM(S): Homo sapiens

PROVIDER: GSE224909 | GEO | 2023/10/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-10-23 | GSE222469 | GEO
2023-10-23 | GSE236365 | GEO
2023-10-23 | GSE224910 | GEO
| PRJNA990712 | ENA
| PRJNA934548 | ENA
2022-06-03 | GSE176305 | GEO
2023-08-29 | PXD040663 | Pride
| PRJNA922169 | ENA
| PRJNA934547 | ENA
2013-01-05 | E-GEOD-43287 | biostudies-arrayexpress